# RIFAXIMIN
> **ANDA219687** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN PHARMACEUTICALS INC · Approved 2026-01-07
## Drug
- **FDA Application Number:** ANDA219687
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIFAXIMIN
- **Generic name:** Rifaximin
- **Active ingredients:** RIFAXIMIN
- **Dosage form:** TABLET
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MYLAN PHARMACEUTICALS INC
- **First approval:** 2026-01-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219687)
---
*AI Analytics · CC0 1.0*